Abstract
This review is being updated and replaced following the publication of a new protocol (Unverzagt S, Moldenhauer I, Coppin C, Greco F, Seliger B. Immunotherapy for metastatic renal cell carcinoma [Protocol]. Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD011673. DOI: 10.1002/14651858.CD011673). It will remain withdrawn when the new review is published.
The editorial group responsible for this previously published document have withdrawn it from publication.
Publication types
-
Meta-Analysis
-
Review
-
Systematic Review
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Bevacizumab
-
Carcinoma, Renal Cell / pathology
-
Carcinoma, Renal Cell / therapy*
-
Humans
-
Immunotherapy*
-
Interferon-alpha / therapeutic use*
-
Interleukin-2 / therapeutic use*
-
Kidney Neoplasms / pathology
-
Kidney Neoplasms / therapy*
-
Randomized Controlled Trials as Topic
-
Survival Analysis
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Interferon-alpha
-
Interleukin-2
-
Bevacizumab